Serum derivative of reactive oxygen metabolites (d-ROMs) in pediatric hemato-oncological patients with neutropenic fever

Pediatric Blood and Cancer

Volumn 55, Issue 1, 2010, Pages 91-94

  Nishikawa, Takuro ^a   Okamoto, Yasuhiro ^a   Kodama, Yuichi ^a   Tanabe, Takayuki ^a   Shinkoda, Yuichi ^a   Kawano, Yoshifumi ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

BAP; d ROMs; Neutropenic fever; Pediatric hemato oncological patients; Reactive oxygen species

Indexed keywords

C REACTIVE PROTEIN; REACTIVE OXYGEN METABOLITE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; DISEASE SEVERITY; FEBRILE NEUTROPENIA; FEMALE; HUMAN; LEUKEMIA; LEUKOCYTE COUNT; LYMPHOMA; MALE; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ADOLESCENT; ADULT; ANTIOXIDANTS; C-REACTIVE PROTEIN; CHILD; CHILD, PRESCHOOL; FEMALE; FEVER; FREE RADICALS; HEMATOLOGIC NEOPLASMS; HUMANS; INFANT; MALE; NEUTROPENIA; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REACTIVE OXYGEN SPECIES; YOUNG ADULT;

EID: 77953278802     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22507     Document Type: Article

References (19)

1. Brinkmann V, Reichard U, Goosmann C, et al. Neutrophil extracellular traps kill bacteria. Science 2004;303:1532-1535. (Pubitemid 38314426)
2. Fuchs TA, Abed U, Goosmann C, et al. Novel cell death program leads to neutrophil extracellular traps. J Cell Biol 2007;176:231-241. (Pubitemid 46143263)
3. Cesarone MR, Belcaro G, Carratelli M, et al. A simple test to monitor oxidative stress. Int Angiol 1999;18:127-130. (Pubitemid 29306588)
4. Dohi K, Satoh K, Ohtaki H, et al. Elevated plasma levels of bilirubin in patients with neurotrauma reflect its pathophysiological role in free radical scavenging. In Vivo 2005;19:855-860. (Pubitemid 41065144)
5. Yamanaka G, Ishii C, Kawashima H, et al. Cerebrospinal fluid Diacron-reactive oxygen metabolite levels in pediatric patients with central nervous system diseases. Pediatr Neurol 2008;39:80-84. (Pubitemid 351970657)
6. Katsabeki-katsafli A, Kerenidi T, Kostikas K, et al. Serum vascular endothelial growth factor is related to systemic oxidative stress in patients with lung cancer. Lung Cancer 2008;60:271-276.
7. Nakayama K, Terawaki H, Nakayama M, et al. Reduction of serum antioxidative capacity during hemodialysis. Clin Exp Nephrol 2007;11:218-224. (Pubitemid 47476795)
8. Hirose H, Kawabe H, Komiya N, et al. Relations between serum reactive oxygen metabolites (ROMs) and various inflammatory and metabolic parameters in a Japanese population. J Atheroscler Thromb 2009;16:77-82.
9. Hughes WT, Armstrong D, Bodey GP, et al. Guidelines for the use of anti microbial agents in neutropenic patient with cancer. Clin Infect Dis 2002;34:730-751. (Pubitemid 34194843)
10. Adams-Chapman I, Stoll BJ. Systemic inflammatory response syndrome. Semin Pediatr Infect Dis 2001;12:5-16.
11. LaTorre F, Orlando A, Silipigni A, et al. Increase of oxygen free radicals and their derivatives in chemo- and radiation-treated neoplasm patients. Minerva Med 1997;88:121-126.
12. Annane D, Bellissant E, Cavaillon JM. Septic shock. Lancet 2005;365:63-78.
13. Harsem NK, Braekke K, Staff AC. Augmented oxidative stress as well as antioxidant capacity in maternal circulation in preeclampsia. Eur J Obstet Gynecol Reprod Biol 2006;128:209-215. (Pubitemid 44311326)
14. Kamezaki F, Yamashita K, Kubara T, et al. Derivatives of reactive oxygen metabolites correlates with high-sensitivity C-reactive protein. J Atheroscler Thromb 2008;15:206-212.
15. Gutteridge JM, Mitchell J. Redox imbalance in the critically ill. Br Med Bull 1999;55:49-75.
16. Gitto E, Karbownik M, Reiter RJ, et al. Effects of melatonin treatment in septic newborns. Pediatr Res 2001;50:756-760. (Pubitemid 33121647)
17. Pascual C, Karzai W, Meier-Hellmann A, et al. Total plasma antioxidant capacity is not always decreased in sepsis. Crit Care Med 1998;26:705-709. (Pubitemid 28201417)
18. Perrsson L, Engervall P, Magnuson A, et al. Use of inflammatory markers for early detection of bacteremia in patients with febrile neutropenia. Scand J Infect Dis 2004;36:365-371. (Pubitemid 38967694)
19. Sakr Y, Sponholz C, Tuche F, et al. The role of procalcitonin in febrile neutropenic patients: Review of the literature. Infection 2008;36:396-407.